CCXI Annual ROE
-39.23%
-14.72%-60.06%
31 December 2021
Summary:
As of February 5, 2025, CCXI annual return on equity is -39.23%, with the most recent change of -14.72% (-60.06%) on December 31, 2021. During the last 3 years, it has risen by +41.54% (+51.43%).CCXI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCXI Quarterly ROE
-46.62%
-1.31%-2.89%
30 June 2022
Summary:
As of February 5, 2025, CCXI quarterly return on equity is -46.62%, with the most recent change of -1.31% (-2.89%) on June 30, 2022. Over the past year, it has dropped by -14.34% (-44.42%).CCXI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCXI ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.1% | -44.4% |
| 3 y3 years | +51.4% | +58.5% |
| 5 y5 years | -241.9% | +21.9% |
CCXI ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -241.9% | -217.6% |
ChemoCentryx ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -46.62%(+2.9%) |
| Mar 2022 | - | -45.31%(+15.5%) |
| Dec 2021 | -39.23%(+60.1%) | -39.24%(+16.5%) |
| Sept 2021 | - | -33.68%(+4.3%) |
| June 2021 | - | -32.28%(+66.3%) |
| Mar 2021 | - | -19.41%(-6.2%) |
| Dec 2020 | -24.51%(-82.2%) | -20.69%(+2.3%) |
| Sept 2020 | - | -20.22%(-7.7%) |
| June 2020 | - | -21.90%(-77.2%) |
| Mar 2020 | - | -95.89%(+1.8%) |
| Dec 2019 | -137.45%(+70.2%) | -94.15%(-7.2%) |
| Sept 2019 | - | -101.42%(-9.7%) |
| June 2019 | - | -112.28%(-5.0%) |
| Mar 2019 | - | -118.22%(+5.8%) |
| Dec 2018 | -80.77%(-392.1%) | -111.73%(-444.7%) |
| Sept 2018 | - | 32.41%(-18.3%) |
| June 2018 | - | 39.65%(+26.0%) |
| Mar 2018 | - | 31.48%(-10.6%) |
| Dec 2017 | 27.65%(-142.3%) | 35.20%(-154.7%) |
| Sept 2017 | - | -64.39%(+7.9%) |
| June 2017 | - | -59.70%(+4.9%) |
| Mar 2017 | - | -56.90%(-15.7%) |
| Dec 2016 | -65.30% | -67.48%(+0.8%) |
| Sept 2016 | - | -66.94%(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | -66.50%(+6.3%) |
| Mar 2016 | - | -62.53%(+19.7%) |
| Dec 2015 | -52.24%(+41.3%) | -52.22%(+8.7%) |
| Sept 2015 | - | -48.02%(+10.8%) |
| June 2015 | - | -43.33%(+8.1%) |
| Mar 2015 | - | -40.09%(+8.9%) |
| Dec 2014 | -36.96%(+22.2%) | -36.83%(+13.4%) |
| Sept 2014 | - | -32.48%(+9.9%) |
| June 2014 | - | -29.55%(+3.3%) |
| Mar 2014 | - | -28.60%(-0.5%) |
| Dec 2013 | -30.25%(-29.4%) | -28.75%(-4.7%) |
| Sept 2013 | - | -30.16%(-5.8%) |
| June 2013 | - | -32.02%(-7.2%) |
| Mar 2013 | - | -34.49%(-1.9%) |
| Dec 2012 | -42.83%(+607.9%) | -35.17%(+204.5%) |
| Sept 2012 | - | -11.55%(+2.2%) |
| June 2012 | - | -11.30%(+25.3%) |
| Mar 2012 | - | -9.02%(+34.0%) |
| Dec 2011 | -6.05%(+50.5%) | -6.73%(-74.9%) |
| Sept 2011 | - | -26.85%(+6.7%) |
| June 2011 | - | -25.17%(+94.7%) |
| Mar 2011 | - | -12.93%(+172.8%) |
| Dec 2010 | -4.02%(-119.9%) | -4.74% |
| Dec 2009 | 20.21% | - |
FAQ
- What is ChemoCentryx annual return on equity?
- What is the all time high annual ROE for ChemoCentryx?
- What is ChemoCentryx annual ROE year-on-year change?
- What is ChemoCentryx quarterly return on equity?
- What is the all time high quarterly ROE for ChemoCentryx?
- What is ChemoCentryx quarterly ROE year-on-year change?
What is ChemoCentryx annual return on equity?
The current annual ROE of CCXI is -39.23%
What is the all time high annual ROE for ChemoCentryx?
ChemoCentryx all-time high annual return on equity is 27.65%
What is ChemoCentryx annual ROE year-on-year change?
Over the past year, CCXI annual return on equity has changed by -14.72% (-60.06%)
What is ChemoCentryx quarterly return on equity?
The current quarterly ROE of CCXI is -46.62%
What is the all time high quarterly ROE for ChemoCentryx?
ChemoCentryx all-time high quarterly return on equity is 39.65%
What is ChemoCentryx quarterly ROE year-on-year change?
Over the past year, CCXI quarterly return on equity has changed by -14.34% (-44.42%)